Tariff reset, shaky tape
The Supreme Court knocked down a prior US administration’s broad tariff program. For US apparel retailers, the first-order impact is simple: fewer duties can drop straight into gross margin for Gap, Aritzia, and Urban Outfitters—unless the sector immediately hands it back via promotions.
But the relief didn’t get to sit. President Trump floated additional tariffs in response, putting the group right back into a stop-start policy loop where lawyers, headlines, and effective dates matter as much as demand. This is less “tariffs down, load the boat” and more “track the calendar and the carve-outs.” The benefit is real, but it won’t feel durable until enforcement and timelines are clear, and it can shift leverage quickly across brands, vendors, and logistics.
Elsewhere on the macro tape, ECB President Christine Lagarde reiterated that Europe can still capture meaningful upside from AI adoption without owning frontier model leadership. That’s supportive for the “implementation wins” trade in slower-growth regions. NYSE and Nasdaq maintaining normal operations through the New York winter storm also removed a small but non-zero market-function variable.
Healthcare split by story
Healthcare didn’t trade as one block; it traded as a referendum on competitive positioning versus execution.
Novo Nordisk (NVO) sold off after results suggested its next-gen obesity shot delivered less weight loss than Eli Lilly’s comparable product. In obesity, investors pay for long-duration share and a generous forward curve. Put up “not as good as the main competitor,” and the stock doesn’t need much help finding downside. The data tightens the funnel, and it forces a refresh of assumptions around share, formularies, and what the category’s endpoint looks like a few years out.
GeneDx (GDX) was basically flat, but it at least offered something you can underwrite: 2026 revenue of $540M–$555M, a sales force expansion, and its Q4 2025 report. No fireworks, but the pitch was clean—targets, levers, and a path to proving it. In a cautious tape, that kind of visibility can draw attention while the mega-theme names deal with pipeline uncertainty.
Credit window stays open
The more durable signal was in funding access. Equity sentiment is patchy, but credit still looks open—and issuers are behaving like they trust the bid.
- Eversource Energy (EVERSOURCE) was little changed after outlining $1.5B via its first hybrid bond issuance for debt refinancing. In utilities, hybrids are the capital-structure multitool: some equity credit, some debt economics, and a way to manage leverage optics without issuing common.
- Exchange Income Corp. (EIF.TO) was also flat as it lined up its first bond sale of up to C$500M (~$365M). An inaugural deal is a market-access test: establish a curve, broaden the buyer base, and prove you can fund outside the bank channel.
For equity holders, this isn’t trivia. A functioning refinancing lane lowers near-term balance-sheet stress and helps put floors under rate-sensitive sectors. It’s hard to overstate how stabilizing it is to watch bond investors calmly write checks when equities are still arguing with the headlines.
What mattered today
- Apparel got real tariff math, but the path forward is still headline-driven.
- NVO took a clean competitive hit in obesity; that pecking order can shift quickly on incremental data.
- GDX didn’t move much, but it delivered measurable targets and execution levers.
- Credit stayed open: first-time hybrid/bond plans from EVERSOURCE and EIF.TO signaled workable market access.
Policy gave apparel a break; markets are waiting to see if it lasts.